Search

Your search keyword '"TAKEUCHI, Satoshi"' showing total 1,450 results
Start Over Author "TAKEUCHI, Satoshi"
1,450 results on '"TAKEUCHI, Satoshi"'

4. Unbound states in 17C and p-sd shell-model interactions

Author

Kim, Sunji, Hwang, Jongwon, Satou, Yoshiteru, Orr, Nigel A., Nakamura, Takashi, Kondo, Yosuke, Gibelin, Julien, Achouri, Nadia Lynda, Aumann, Thomas, Baba, Hidetada, Delaunay, Franck, Doornenbal, Pieter, Fukuda, Naoki, Inabe, Naohito, Isobe, Tadaaki, Kameda, Daisuke, Kanno, Daiki, Kobayashi, Nobuyuki, Kobayashi, Toshio, Kubo, Toshiyuki, Leblond, Sylvain, Lee, Jenny, Marqués, Francisco Miguel, Minakata, Ryogo, Motobayashi, Tohru, Murai, Daichi, Murakami, Tetsuya, Muto, Kotomi, Nakashima, Tomohiro, Nakatsuka, Noritsugu, Navin, Alahari, Nishi, Seijiro, Ogoshi, Shun, Otsu, Hideaki, Sato, Hiromi, Shimizu, Yohei, Suzuki, Hiroshi, Takahashi, Kento, Takeda, Hiroyuki, Takeuchi, Satoshi, Tanaka, Ryuki, Togano, Yasuhiro, Tuff, Adam G., Vandebrouck, Marine, and Yoneda, Ken-ichiro

Subjects
Nuclear Experiment, Nuclear Theory
Abstract

Unbound states in 17C were investigated via one-neutron removal from a 18C beam at an energy of 245 MeV/nucleon on a carbon target. The energy spectrum of 17C, above the single-neutron decay threshold, was reconstructed using invariant mass spectroscopy from the measured momenta of the 16C fragment and neutron, and was found to exhibit resonances at Er=0.52(2), 0.77(2), 1.36(1), 1.91(1), 2.22(3) and 3.20(1) MeV. The resonance at Er=0.77(2) MeV [Ex=1.51(3) MeV] was provisionally assigned as the second 5/2+ state. The two resonances at Er=1.91(1) and 3.20(1) MeV [Ex=2.65(2) and 3.94(2) MeV] were identified, through comparison of the energies, cross sections and momentum distributions with shell-model and eikonal reaction calculations, as p-shell hole states with spin-parities 1/2- and 3/2-, respectively. A detailed comparison was made with the results obtained using a range of shell-model interactions. The YSOX shell-model Hamiltonian, the cross-shell part of which is based on the monopole-based universal interaction, was found to provide a very good description of the present results and those for the neighbouring odd-A carbon isotopes - in particular for the negative parity cross-shell states., Comment: Physics Letters B 836 (2023) 137629, published

Published
2022
Full Text
View/download PDF

8. Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study

Author

Takeuchi, Satoshi, Hirata, Kenji, Magota, Keiichi, Watanabe, Shiro, Moku, Rika, Shiiya, Akihiko, Taguchi, Jun, Ariga, Shin, Goda, Tomohiro, Ohhara, Yoshihito, Noguchi, Takurou, Shimizu, Yasushi, Kinoshita, Ichiro, Honma, Rio, Tsuji, Yasushi, Homma, Akihiro, and Dosaka-Akita, Hirotoshi

Published
2023
Full Text
View/download PDF

13. An exploratory study of the efficacy and safety of amenamevir for the treatment of herpes zoster in patients receiving immunosuppressive drugs.

Author

Imafuku, Shinichi, Takeuchi, Satoshi, Urabe, Kazunori, Arakawa, Masataka, Sasaki, Ryo, Oka, Daigo, Yamamoto, Takenobu, Ono, Fumitake, Shirahama, Shigeho, Yasumoto, Shinichiro, and Fukuda, Hiroaki

Abstract

Amenamevir is an oral once‐daily antiherpesvirus drug that can be administered without dose adjustment in patients with impaired renal function. There are currently no clinical data on immunocompromised patients with herpes zoster treated with amenamevir. Therefore, an exploratory study of the efficacy and safety of amenamevir against herpes zoster in patients with immunosuppression was conducted. Inclusion criteria included patients with acute herpes zoster receiving immunosuppressive drugs or those with malignant tumors or autoimmune diseases. Twenty‐four patients were included and received amenamevir (400 mg once daily after meals) for up to 14 days. The primary end point of overall improvement in skin symptoms 7 days after treatment initiation (day 7) was 58.3% for "markedly improved" and 20.8% for "improved." The combined improvement rate was 79.2% (95% confidence interval, 57.8–92.9), and 20.8% of patients experienced "worsened" symptoms. The secondary end points of overall improvement in skin symptoms on day 14 and day 28 were 95.7% and 100%, respectively. The skin symptoms progressed during treatment, peaking on day 7, and then began to heal. By Kaplan–Meier estimation, the median periods to complete crusting and healing were both day 14. There were five adverse events with a possible causal relationship to amenamevir (bacterial skin infection, anemia, hyponatremia, headache, and abnormal liver function) in one of the 24 patients. Although the bacterial skin infection was severe, all events in this patient were reported to be either recovered or recovering. These findings indicate that amenamevir can be effective and safe in immunocompromised patients with herpes zoster. However, as worsening can happen around day 7, it is necessary to carefully monitor such patients and switch to other therapies such as intravenous acyclovir if necessary. Clinical trial identifier: Japan Registry of Clinical Trials jRCTs031190208. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Predictive Factors of Early 18F-Fluorodeoxyglucose-Positron Emission Tomography Response to [131I] Metaiodobenzylguanidine Treatment for Unresectable or Metastatic Pheochromocytomas and Paragangliomas.

Author

Takenaka, Junki, Watanabe, Shiro, Abe, Takashige, Tsuchikawa, Takahiro, Takeuchi, Satoshi, Hirata, Kenji, Kimura, Rina, Wakabayashi, Naoto, Shinohara, Nobuo, and Kudo, Kohsuke

Subjects
LOGISTIC regression analysis, NEUROENDOCRINE tumors, PROGNOSIS, OVERALL survival, TREATMENT effectiveness
Abstract

Introduction: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours that produce catecholamines. [131I] metaiodobenzylguanidine (MIBG)-avid unresectable or metastatic PPGLs are treated with [131I] MIBG radionuclide therapy. A high metabolic tumour volume (MTV) and total lesion glycolysis (TLG) can be poor prognostic factors. Therefore, we evaluated the metabolic responses to [131I] MIBG therapy with respect to other clinical factors. Methods: A retrospective study was performed on a series of 20 patients who underwent FDG-PET before and after [131I] MIBG therapy. We administered a single dose comprising 5.5 GBq of [131I] MIBG (usually three times; for some cases, the number was increased or decreased considering treatment efficacy and side effects). Semi-quantitative parameters (SUVmax, MTV, and TLG) were calculated using the liver SUV (mean + 3 × standard deviation) as a threshold on Metavol software. The semi-quantitative FDG-PET parameters for determining response were complete response (CR), partial remission (PR), stable disease (SD), and progressive disease (PD). We divided our study participants into the PD and non-PD groups (i.e., SD + PR + CR) and compared the overall survival (OS) between the two groups. Subsequently, we evaluated the relationships between metabolic response and age, sex, tumour type, metastatic site, chemotherapy or external radiation history, and 24-h urine catecholamine levels by univariate logistic regression analyses. Results: Both MTV-based and TLG-based criteria for PD versus non-PD were significant prognostic factors (p = 0.014). However, treatment response as evaluated based on the SUVmax was not a significant predictor. Higher urinary dopamine levels were associated with poor metabolic response as assessed by MTV and TLG (OR 1.002, p = 0.029). The other clinical parameters were non-significant. Conclusion: Poor metabolic response (measured with MTV and TLG) to [131I] MIBG therapy in unresectable or metastatic PPGLs was related to shorter OS. The poor metabolic response can be predicted using the urinary dopamine level. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Prognostic impact of heart failure admission in survivors of acute myocardial infarction.

Author

Takeuchi, Satoshi, Honda, Satoshi, Nishihira, Kensaku, Kojima, Sunao, Takegami, Misa, Asaumi, Yasuhide, Saji, Mike, Yamashita, Jun, Hibi, Kiyoshi, Takahashi, Jun, Sakata, Yasuhiko, Takayama, Morimasa, Sumiyoshi, Tetsuya, Ogawa, Hisao, Kimura, Kazuo, and Yasuda, Satoshi

Subjects
MAJOR adverse cardiovascular events, PERCUTANEOUS coronary intervention, HEART failure, CEREBRAL infarction, HEART failure patients, VENTRICULAR ejection fraction, MYOCARDIAL infarction
Abstract

Aims: The incidence and prognosis of symptomatic heart failure following acute myocardial infarction (AMI) in the primary percutaneous coronary intervention era have rarely been reported in the literature. This study aimed to (i) determine the incidence of heart failure admission among AMI survivors, (ii) compare 1 year outcomes between patients with heart failure admission and those without, and (iii) identify the independent risk factors associated with heart failure admission. Methods and results: The Japan Acute Myocardial Infarction Registry is a prospective multicentre registry from which data on consecutively enrolled patients with AMI from 50 institutions between 2015 and 2017 were obtained. Among the 3411 patients enrolled, 3226 who survived until discharge were included in this study. The primary endpoint was all‐cause mortality. The secondary endpoints were major adverse cardiovascular events (defined as cardiovascular mortality, non‐fatal myocardial infarction, or non‐fatal cerebral infarction) and major bleeding events corresponding to Bleeding Academic Research Consortium Type 3 or 5. Clinical outcomes were compared between the patients who were and were not admitted for heart failure. Over a median follow‐up of 12 months, 124 patients (3.8%) were admitted due to heart failure. Independent risk factors for heart failure admission included older age, female sex, Killip class ≥2 on admission, left ventricular ejection fraction <40%, estimated glomerular filtration rate ≤30 mL/min/1.73 m2, a history of malignancy, and non‐use of angiotensin‐converting enzyme inhibitors at discharge. The cumulative incidence of all‐cause mortality was significantly higher in the heart failure admission group than in the no heart failure admission group (11.3% vs. 2.5%, P < 0.001). The rates of major adverse cardiovascular events (16.9% vs. 2.7%, P < 0.001) and major bleeding (6.5% vs. 1.6%, P < 0.001) were significantly higher in the heart failure admission group. Heart failure admission was associated with a higher risk of all‐cause mortality, even after adjusting for potential confounders (adjusted hazard ratio: 2.41, 95% confidence interval: 1.33–4.39, P = 0.004). Conclusions: Utilizing real‐world data of the contemporary percutaneous coronary intervention era from the Japan Acute Myocardial Infarction Registry database, this study demonstrates that the heart failure admission of AMI survivors was significantly associated with higher all‐cause mortality rates. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Spectroscopy of 17C Above the Neutron Separation Energy

Author

Kim, Sunji, Hwang, Jongwon, Satou, Yoshiteru, Orr, Nigel A., Nakamura, Takashi, Kondo, Yosuke, Gibelin, Julien, Achouri, N. Lynda, Aumann, Thomas, Baba, Hidetada, Delaunay, Franck, Doornenbal, Pieter, Fukuda, Naoki, Inabe, Naohito, Isobe, Tadaaki, Kameda, Daisuke, Kanno, Daiki, Kobayashi, Nobuyuki, Kobayashi, Toshio, Kubo, Toshiyuki, Leblond, Sylvain, Lee, Jenny, Marqués, F. Miguel, Minakata, Ryogo, Motobayashi, Tohru, Murai, Daichi, Murakami, Tetsuya, Muto, Kotomi, Nakashima, Tomohiro, Nakatsuka, Noritsugu, Navin, Alahari, Nishi, Seijiro, Ogoshi, Shun, Otsu, Hideaki, Sato, Hiromi, Shimizu, Yohei, Suzuki, Hiroshi, Takahashi, Kento, Takeda, Hiroyuki, Takeuchi, Satoshi, Tanaka, Ryuki, Togano, Yasuhiro, Tuff, Adam G., Vandebrouck, Marine, and Yoneda, Ken-ichiro

Published
2022
Full Text
View/download PDF

30. Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: Practical biomarkers and robust multiplex models

Author

Kawabata-Iwakawa, Reika, primary, Iwasa, Norihiro, additional, Satoh, Kenichi, additional, Colinge, Jacques, additional, Shimada, Muneaki, additional, Takeuchi, Satoshi, additional, Fujiwara, Hiroyuki, additional, Eguchi, Hidetaka, additional, Oishi, Tetsuro, additional, Sugiyama, Toru, additional, Suzuki, Mitsuaki, additional, Hasegawa, Kosei, additional, Fujiwara, Keiichi, additional, and Nishiyama, Masahiko, additional

Published
2024
Full Text
View/download PDF

35. Transient improvement of urticaria induces poor adherence as assessed by Morisky Medication Adherence Scale‐8

Author

Kaneko, Sakae, Masuda, Koji, Hiragun, Takaaki, Inomata, Naoko, Furue, Masutaka, Onozuka, Daisuke, Takeuchi, Satoshi, Murota, Hiroyuki, Sugaya, Makoto, Saeki, Hidehisa, Shintani, Yoichi, Tsunemi, Yuichiro, Abe, Shinya, Kobayashi, Miwa, Kitami, Yuki, Tanioka, Miki, Imafuku, Shinichi, Abe, Masatoshi, Hagihara, Akihito, Morisky, Donald E, and Katoh, Norito

Subjects
Pharmacology and Pharmaceutical Sciences, Biomedical and Clinical Sciences, Clinical Research, 5.1 Pharmaceuticals, Management of diseases and conditions, Evaluation of treatments and therapeutic interventions, Development of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 7.1 Individual care needs, Administration, Oral, Administration, Topical, Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Japan, Male, Medication Adherence, Middle Aged, Surveys and Questionnaires, Urticaria, Young Adult, adherence, oral, topical, transient improvement, urticaria, Clinical Sciences, Dermatology & Venereal Diseases, Clinical sciences
Abstract

Poor adherence to medication is a major public health challenge. Here, we aimed to determine the adherence to oral and topical medications and to analyze underlying associated factors using the translated Japanese version of Morisky Medication Adherence Scale-8 regarding urticaria treatment. Web-based questionnaires were performed for 3096 registered dermatological patients, along with a subanalysis of 751 registered urticaria patients in this study. The adherence to oral medication was significantly associated with the frequency of hospital visits. Variables that affected the adherence to topical medication included age and experience of drug effectiveness. The rate of responses that "It felt like the symptoms had improved" varied significantly among the dermatological diseases treated with oral medications. Dermatologists should be aware that adherence to the treatment of urticaria is quite low. Regular visits and active education for patients with urticaria are mandatory in order to achieve a good therapeutic outcome by increasing the adherence.

Published
2015

36. Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation

Author

Murota, Hiroyuki, Takeuchi, Satoshi, Sugaya, Makoto, Tanioka, Miki, Onozuka, Daisuke, Hagihara, Akihito, Saeki, Hidehisa, Imafuku, Shinichi, Abe, Masatoshi, Shintani, Yoichi, Kaneko, Sakae, Masuda, Koji, Hiragun, Takaaki, Inomata, Naoko, Kitami, Yuki, Tsunemi, Yuichiro, Abe, Shinya, Kobayashi, Miwa, Morisky, Donald E, Furue, Masutaka, and Katoh, Norihito

Subjects
Pharmacology and Pharmaceutical Sciences, Biomedical and Clinical Sciences, Clinical Research, Behavioral and Social Science, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, 7.1 Individual care needs, Management of diseases and conditions, Skin, Administration, Cutaneous, Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Alcohol Drinking, Dermatitis, Atopic, Dermatologic Agents, Employment, Female, Humans, Japan, Male, Marital Status, Medication Adherence, Middle Aged, Patient Satisfaction, Sex Factors, Surveys and Questionnaires, Treatment Outcome, Young Adult, Atopic dermatitis, Adherence, Morisky Medication Adherence Scale-8, Treatment satisfaction, Clinical Sciences, Dermatology & Venereal Diseases, Clinical sciences
Abstract

BackgroundPatients' high adherence to medication is indispensable for the management of skin diseases including atopic dermatitis. We previously showed poor medication adherence in Japanese dermatological patients.ObjectiveThis study was conducted to determine the level of adherence to oral or topical medication in Japanese patients with atopic dermatitis, attempting to characterize the socioeconomic status of those patients with poor adherence.MethodsA web questionnaire survey on demographic data as well as adherence level was conducted on patients registered in the monitoring system. Adherence level was assessed with Morisky Medication Adherence Scale-8 (MMAS-8). Among a total of 3096 respondents with dermatological disorders, data of 1327 subjects with atopic dermatitis were extracted and analyzed.ResultsMore than 80% of subjects felt that both oral and topical medications were safe and efficacious, while less than 60% of them were satisfied with their treatment. Levels of adherence to oral and topical treatments were evaluated with MMAS-8, giving scores of 4.6 and 4.2, respectively. Demographic factors such as gender, marital status, state of employment, alcohol consumption, frequency of hospital visits, and experience of drug effectiveness had a significant impact on the degree of adherence to treatment.ConclusionMedication adherence level in Japanese subjects with atopic dermatitis was relatively low compared with that of other chronic diseases. Our survey has characterized patients with poor adherence, who are good targets for interventions to maximize potentially limited healthcare resources.

Published
2015

37. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale‐8 and low satisfaction with treatment in 237 psoriasis patients

Author

Saeki, Hidehisa, Imafuku, Shinichi, Abe, Masatoshi, Shintani, Yoichi, Onozuka, Daisuke, Hagihara, Akihito, Katoh, Norito, Murota, Hiroyuki, Takeuchi, Satoshi, Sugaya, Makoto, Tanioka, Miki, Kaneko, Sakae, Masuda, Koji, Hiragun, Takaaki, Inomata, Naoko, Kitami, Yuki, Tsunemi, Yuichiro, Abe, Shinya, Kobayashi, Miwa, Morisky, Donald E, and Furue, Masutaka

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Psoriasis, Clinical Research, 7.1 Individual care needs, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Management of diseases and conditions, Skin, Administration, Topical, Adult, Aged, Aged, 80 and over, Dermatologic Agents, Female, Humans, Japan, Male, Medication Adherence, Middle Aged, Patient Satisfaction, Skin Diseases, Surveys and Questionnaires, Young Adult, adherence, Morisky Medication Adherence Scale-8, psoriasis, sociomedical factor, treatment satisfaction, Dermatology & Venereal Diseases, Clinical sciences
Abstract

Previously we assessed the medication adherence for oral and topical remedies by a translated Japanese version of the Morisky Medication Adherence Scale-8 (MMAS-8) together with socioeconomic backgrounds in 3096 Japanese dermatological patients, and found the medication adherence, especially to topical drugs, was poor in these patients. In order to elucidate the disease-specific sociomedical factors, we further sub-analyzed the medication adherence in 237 psoriasis patients and compared it with that in other dermatological diseases such as atopic dermatitis, urticaria or tinea. This study was conducted among patients registered in monitoring system and 3096 eligible patients were enrolled. Our web-based questionnaire included the following items such as age, sex, annual income, main health-care institution, experience of effectiveness by oral or topical medication, overall satisfaction with treatment, and MMAS-8 for oral or topical medication. Mean adherence score by MMAS-8 was 5.2 for oral and 4.3 for topical medication. More patients with psoriasis used a university hospital and fewer used a private clinic compared with those with the other skin disease patients. Experience of drug effectiveness by oral medication and overall satisfaction with treatment was lower in psoriasis patients than in other patients. In oral medication, significantly better adherence was observed in those of higher age and with higher annual income. The adherence to medication, especially to topical drugs, was poor in 237 psoriasis patients. We speculated that some severe psoriasis patients were not sufficiently treated systemically and were resistant to topical therapy, leading to poor adherence.

Published
2015

40. Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years

Author

Matsuo, Koji, Ross, Malcolm S., Yunokawa, Mayu, Johnson, Marian S., Machida, Hiroko, Omatsu, Kohei, Klobocista, Merieme M., Im, Dwight D., Satoh, Shinya, Baba, Tsukasa, Ikeda, Yuji, Bush, Stephen H., Hasegawa, Kosei, Blake, Erin A., Takekuma, Munetaka, Shida, Masako, Nishimura, Masato, Adachi, Sosuke, Pejovic, Tanja, Takeuchi, Satoshi, Yokoyama, Takuhei, Ueda, Yutaka, Iwasaki, Keita, Miyake, Takahito M., Yanai, Shiori, Nagano, Tadayoshi, Takano, Tadao, Shahzad, Mian MK., Ueland, Frederick R., Kelley, Joseph L., and Roman, Lynda D.

Published
2019
Full Text
View/download PDF

41. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Author

Vergote, Ignace, Scambia, Giovanni, Park, Sang Yoon, Song, Yong Sang, Makarova, Yulia, Trinidad, Joshua, Ngan, Hextan Yuen Sheung, Bamias, Aristotelis, Aravantinos, Gerasimos, Nam, Joo-Hyun, Gorbunova, Vera, Krikunova, Ludmila, Bae, Duk-Soo, Arija, Jose Angel Arranz, Mirza, Mansoor Raza, Zamagni, Claudio, Papandreou, Christos, Raspagliesi, Francesco, Lisyanskaya, Alla, Benzaquen, Ana Oaknin, Tognon, Germana, Ortega, Eugenia, Herraez, Antonio Casado, Buscema, Joseph, Green, Andrew, Burger, Robert, Sakaeva, Dina, Sanchez, Andres Redondo, Ghamande, Sharad, King, Laurel, Petru, Edgar, Peen, Ulla, Takeuchi, Satoshi, Ushijima, Kimio, Martin, Antonio Gonzalez, Kamelle, Scott, Carney, Michael, Marth, Christian, Forget, Frédéric, Bentley, James, Sehouli, Jalid, Colombo, Nicoletta, Zola, Paolo, Kato, Hidenori, Fadeeva, Natalya, Gotovkin, Evgeny, Vladimirov, Vladimir, Marin, Margarita Romeo, Alia, Eva Guerra, Shahin, Mark, Bhoola, Snehalkumar, Tewari, Krishnansu, Anderson, Daniel, Honhon, Brigitte, Pelgrims, Joseph (Gino), Oza, Amit, Jimenez, Jesus Garcia-Donas, Hansen, Vincent, O'Malley, David, Benjamin, Ivor, Renard, Vincent, Van den Bulck, Heidi, Meier, Werner, Haenle, Claudia, Koumakis, Georgios, Yokota, Harushige, Popov, Vadim, Bradley, William, Wenham, Robert, Reid, Robert, McNamara, Donna, Friedman, Richard, Barlin, Joyce, Spirtos, Nicola, Chapman, Julia, Sevelda, Paul, Huizing, Manon, Lamot, Caroline, Goffin, Frédéric, Hondt, Lionel D, Covens, Allan, Spadafora, Silvana, Rautenberg, Beate, Reimer, Toralf, Möbus, Volker, Hilpert, Felix, Gropp-Meier, Martina, Savarese, Antonella, Pignata, Sandro, Verderame, Francesco, Mizuno, Mika, Takano, Hirokuni, Ottevanger, Petronella, Velasco, Andres Poveda, Palacio-Vazquez, Isabel, Law, Amy, McIntyre, Kristi, Teneriello, Michael, Fields, Abbie, Lentz, Samuel, Street, Daron, Schwartz, Benjamin, Mannel, Robert, Lim, Peter, Pulaski, Heather, Janni, Wolfgang, Zorr, Andreas, Karck, Ulrich, Cheng, Ashley Chi Kin, Sorio, Roberto, Gridelli, Cesare, Aoki, Daisuke, Oishi, Tetsuro, Hirashima, Yasuyuki, Boere, Ingrid, Ferrer, Esther Falco, Braly, Patricia, Wilks, Sharon, Lee, Christine, Schilder, Jeanne, Veljovich, Dan, Secord, Angeles, Davis, Kevin, Rojas-Espaillat, Luis, Lele, Shashikant, DePasquale, Stephen, Squatrito, Robert, Schauer, Christian, Dirix, Luc, Vuylsteke, Peter, Joosens, Eric, Provencher, Diane, Lueck, Hans-Joachim, Hein, Alexander, Burges, Alexander, Canzler, Ulrich, Park-Simon, Tjoung-Won, Griesinger, Frank, Gadducci, Angiolo, Alabiso, Oscar, Okamoto, Aikou, Sawasaki, Takashi, Saito, Toshiaki, Ibañez, Ana Herrero, Calomeni, Coralia, Spillman, Monique, Choksi, Janak, Taylor, Nicholas, Muller, Carolyn, Moore, David, DiSilvestro, Paul, Cunningham, Mary, Rose, Peter, Oppelt, Peter, Verhoeven, Didier, Graas, Marie-Pascale, Ghatage, Prafull, Tonkin, Katia, Kurzeder, Christian, Schnappauf, Benjamin, Müller, Volkmar, Schmalzrie, Hannah, Kalofonos, Haralambos, Bruzzone, Milena, Kroep, Judith, Diaz, Cristina Caballero, Garcia, Jeronimo Martinez, Polo, Susana Hernando, Garrison, Mitchell, Rocconi, Rodney, Andrews, Stephen, Bristow, Robert, McHale, Michael, Basil, Jack, Houck III, William, Bell, Maria, Cosin, Jonathan, Modesitt, Susan, Kendrick, James, Wade III, James, Wong, Cheung, Evans, Anthony, Buekers, Thomas, Vanderkwaak, Timothy, Ferriss, James, Darus, Christopher, DAndre, Stacy, Higgins, Robert, Monk, Bradley, Bakkum-Gamez, Jamie, DeMars, Leslie, Van Le, Linda, Puls, Larry, Trehan, Shruti, LaPolla, James, Michelson, Elizabeth Dickson, Merchant, Joseph, Peterson, Christopher, Reid, Gary, Seago, Donald, Zweizig, Susan, Gajewski, Walter, Panwalkar, Amit, Leikermoser, Rudolf, Bogner, Gerhard, Debruyne, Philip, D'hondt, Randal, Berteloot, Patrick, Kerger, Joseph, Biagi, James, Castonguay, Vincent, Welch, Stephen, Muhic, Aida, Heubner, Martin, Grischke, Eva-Maria, Rack, Brigitte, Fleisch, Markus, Lordick, Florian, Pectasides, Dimitrios, Ho, Wing Ming, Selvaggi, Luigi, Vasquez, Flavia Morales, Villanueva, William Orlando Brito, Alavez, Alejandro Molina, Kessels, Lonneke, Bertran, Ana Santaballa, Fernandez, Cesar Mendiola, Fabregat, Miguel Beltran, Del Prete, Salvatore, Elkas, John, Cecchi, Gary, Kumar, Pallavi, Huh, Warner, Messing, Mark, Karimi, Misagh, Kelley, Ann, Edraki, Babak, Mutch, David, Leiserowitz, Gary, Anderson, Jeanne, Lentz, Scott, Chambers, Setsuko, Morris, Robert, Waggoner, Steven, Gordon, Alan, Method, Michael, Johnson, Peter, Lord, Raymond, Drake, Janet, Sivarajan, Kulumani, Midathada, Madhu, Rice, Kristen, Wadsworth, Troy, Pavelka, James, Edwards, Robert, Miller, David Scott, Ford, Patricia Locantore, Hurteau, Jean, Bender, David, Schimp, Veronica, Creasman, William, Lerner, Rachel, Chamberlain, Donald, Kueck, Angela, McDonald, John, Malad, Salman, Robinson-Bennett, Bernice, Davidson, Susan, Krivak, Thomas, Lestingi, Timothy, Arango, Hector, Berard, Paul, Finkelstein, Karen, Gaur, Rakesh, Krasner, Carolyn, Ueland, Frederick, Talmage, Lance, Yamada, Seiko, Sutton, Gregory, Potkul, Ronald, Prasad-Hayes, Monica, Osborne, Janet, Celano, Paul, Thigpen, James, Sharma, Sudarshan, Schilder, Russell, Tammela, Jonathan, Kemeny, Mary, Brown, Amy, Eisenhauer, Eric, Williams, James, Rowland, Kendrith, Nahum, Kenneth, Burke, James, Dar, Zahid, Fleming, Nicole, Gibb, Randall, Guirguis, Alfred, Herzog, Thomas, John, Veena, Kumar, Santhosh, Kamat, Aparna, Kassar, Mohamad, Leitao, Mario, Levine, Lyuba, Mendez, Luis, Patel, Dhimant, Berry, Emily, Warshal, David, Wolf, Judith, Zarwan, Corrine, Collins, Yvonne, Spitzer, Gary, Miller, Brigitte, Einstein, Mark, O'Malley, David M, Van Calster, Ben, Park, Sang-Yoon, del Campo, Josep M, Wenham, Robert M, Covens, Al, Raza Mirza, Mansoor, Kroep, Judith R, Ma, Haijun, Pickett, Cheryl A, and Monk, Bradley J

Published
2019
Full Text
View/download PDF

44. Physiological effects of appropriate washing on xerotic skin.

Author

Takeuchi, Satoshi, Murakami, Yumi, Matsunaka, Hiroshi, Nakahara, Takeshi, and Furue, Masutaka

Subjects
*SKIN care products, *ATOPIC dermatitis, *SKIN care, *SYMPTOMS, *SKIN diseases, *DECONTAMINATION of food
Abstract

Background: Daily skin care is important for treatment of skin diseases, but few studies have reported on appropriate washing methods. Aim: This study aimed to provide guidance on washing techniques and examine changes in skin condition after using the recommended washing technique and foaming‐type skin cleanser in patients with atopic or asteatotic dermatitis. Methods: An internet‐based questionnaire survey on skin symptoms and cleaning methods was conducted. Further, a left–right comparative, nonrandomized trial was performed in 19 patients with asteatotic or atopic dermatitis and xerosis. Participants were instructed to wash with a cotton towel and their normal cleanser during Weeks 1–4 and with bare hands or a cotton towel and the recommended foaming‐type cleanser during Weeks 5–8. Results: The survey revealed that the degree of lathering differed depending on the cleaning tool. In the trial, scores for erythema, desquamation, and xerosis in the lower legs were significantly reduced after 4 weeks compared with scores at the start. Between Weeks 4 and 8, scores for erythema, xerosis, and pruritus in the inner forearm on the side washed with bare hands and scores for xerosis, pruritus, and excoriation on the side washed with a cotton towel were significantly reduced. A significant increase was noted in stratum corneum ceramide content on both left and right inner forearms, whereas a significant decrease was noted in stratum corneum thymus and activation‐regulated chemokine level ratios in the lower legs on both sides. Conclusions: Xerotic skin disease symptoms can be improved using appropriate body washing methods. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

47. Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element

Author

Matsuo, Koji, Takazawa, Yutaka, Ross, Malcolm S., Elishaev, Esther, Yunokawa, Mayu, Sheridan, Todd B., Bush, Stephen H., Klobocista, Merieme M., Blake, Erin A., Takano, Tadao, Baba, Tsukasa, Satoh, Shinya, Shida, Masako, Ikeda, Yuji, Adachi, Sosuke, Yokoyama, Takuhei, Takekuma, Munetaka, Yanai, Shiori, Takeuchi, Satoshi, Nishimura, Masato, Iwasaki, Keita, Johnson, Marian S., Yoshida, Masayuki, Hakam, Ardeshir, Machida, Hiroko, Mhawech-Fauceglia, Paulette, Ueda, Yutaka, Yoshino, Kiyoshi, Kajiwara, Hiroshi, Hasegawa, Kosei, Yasuda, Masanori, Miyake, Takahito M., Moriya, Takuya, Yuba, Yoshiaki, Morgan, Terry, Fukagawa, Tomoyuki, Pejovic, Tanja, Nagano, Tadayoshi, Sasaki, Takeshi, Richmond, Abby M., Post, Miriam D., Shahzad, Mian M.K., Im, Dwight D., Yoshida, Hiroshi, Omatsu, Kohei, Ueland, Frederick R., Kelley, Joseph L., Karabakhtsian, Rouzan G., and Roman, Lynda D.

Published
2018
Full Text
View/download PDF

49. Significance of venous thromboembolism in women with uterine carcinosarcoma

Author

Matsuo, Koji, Ross, Malcolm S., Im, Dwight D., Klobocista, Merieme M., Bush, Stephen H., Johnson, Marian S., Takano, Tadao, Blake, Erin A., Ikeda, Yuji, Nishimura, Masato, Ueda, Yutaka, Shida, Masako, Hasegawa, Kosei, Baba, Tsukasa, Adachi, Sosuke, Yokoyama, Takuhei, Satoh, Shinya, Machida, Hiroko, Yanai, Shiori, Iwasaki, Keita, Miyake, Takahito M., Takeuchi, Satoshi, Takekuma, Munetaka, Nagano, Tadayoshi, Yunokawa, Mayu, Pejovic, Tanja, Omatsu, Kohei, Shahzad, Mian M.K., Kelley, Joseph L., Ueland, Frederick R., and Roman, Lynda D.

Published
2018
Full Text
View/download PDF

50. Spallation reaction study for the long-lived fission products in nuclear waste: Cross section measurements for 137Cs, 90Sr and 107Pd using inverse kinematics method

Author

Wang, He, Otsu, Hideaki, Sakurai, Hiroyoshi, Ahn, DeukSoon, Chiga, Nobuyuki, Doornenbal, Pieter, Fukuda, Naoki, Isobe, Tadaaki, Kubo, Toshiyuki, Kubono, Shigeru, Lorusso, Giusseppe, Söderström, Pär-Anders, Suzuki, Hiroshi, Takeda, Hiroyuki, Watanabe, Yasushi, Yoshida, Koichi, Matsuzaki, Teiichiro, Shimizu, Yohei, Sumikama, Toshiyuki, Uesaka, Meiko, Kawase, Shoichiro, Nakano, Keita, Watanabe, Yukinobu, Araki, Shouhei, Kin, Tadahiro, Takeuchi, Satoshi, Togano, Yasuhiro, Nakamura, Takashi, Kondo, Yosuke, Ozaki, Tomoyuki, Saito, Atsumi, Tsubota, Junichi, Aikawa, Masayuki, Makinaga, Ayano, Ando, Takashi, Koyama, Shunpei, Momiyama, Satoru, Nagamine, Shunsuke, Niikura, Megumi, Saito, Takeshi, Taniuchi, Ryo, Wimmer, Kathrin, Kawakami, Shunsuke, Maeda, Yukie, Yamamoto, Tatsuya, Shiga, Yoshiaki, Matsushita, Masafumi, Michimasa, Shin’ichiro, and Shimoura, Susumu

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results